James Fetten
Impact in
- Otorhinolaryngology top 5%
- Head and Neck Cancer Studies
- Hematology top 10%
- Hemophilia Treatment and Research
- Platelet Disorders and Treatments
Papers in
- Oncology 15
- Cancer Immunotherapy and Biomarkers 5
- Cancer Treatment and Pharmacology 3
-
- Lung Cancer Treatments and Mutations 3
- Co-authors
- Willi Kreis (2 shared papers)Daniel R. Budman (2 shared papers)V. Vinciguerra (1 shared paper)Myron Susin (2 shared papers)Savita Pahwa (2 shared papers)Mark H. Kaplan (2 shared papers)Stuart M. Lichtman (2 shared papers)Steven L. Allen (2 shared papers)
- Journals
- Journal of Clinical Oncology (11 papers)The American Journal of Medicine (2 papers)Breast Cancer Research and Treatment (2 papers)JCO Global Oncology (1 paper)CA A Cancer Journal for Clinicians (1 paper)
- Partner nations
- United StatesChinaThailand
In The Last Decade
James Fetten
28 papers receiving 670 citations
Peers
Comparison fields: 5 of 59
- Otorhinolaryngology 78
- Hematology 93
- Oncology 194
- Virology 29
- Pulmonary and Respiratory Medicine 160
Countries citing papers authored by James Fetten
This map shows the geographic impact of James Fetten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Fetten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Fetten more than expected).
Fields of papers citing papers by James Fetten
This network shows the impact of papers produced by James Fetten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Fetten. The network helps show where James Fetten may publish in the future.
Co-authors
The 25 scholars most cited alongside James Fetten, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1999 | 135 | |
| 2 | 1987 | 108 | |
| 3 | Human coagulation factor FVIIa (recombinant) in the management of limb-threatening bleeds unresponsive to alternative therapies: results from the NovoSeven emergency-use programme in patients with severe haemophilia or with acquired inhibitors. | 2000 | 55 |
| 4 | 2021 | 52 | |
| 5 | 1991 | 46 | |
| 6 | 1991 | 42 | |
| 7 | 2022 | 40 | |
| 8 | 2019 | 32 | |
| 9 | 1985 | 24 | |
| 10 | 1999 | 24 | |
| 11 | 2022 | 23 | |
| 12 | 2024 | 16 | |
| 13 | 1996 | 16 | |
| 14 | 2021 | 13 | |
| 15 | 2024 | 11 | |
| 16 | 1997 | 11 | |
| 17 | 2020 | 8 | |
| 18 | 2023 | 7 | |
| 19 | 2019 | 7 | |
| 20 | 2021 | 6 |
About James Fetten
James Fetten is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Otorhinolaryngology, Surgery and Radiology, Nuclear Medicine and Imaging, having authored 30 papers that have together received 694 indexed citations. Recurring topics across this work include Head and Neck Cancer Studies (7 papers), Cancer Immunotherapy and Biomarkers (5 papers), Cancer Treatment and Pharmacology (3 papers), Thyroid Cancer Diagnosis and Treatment (3 papers), Colorectal and Anal Carcinomas (3 papers), Salivary Gland Tumors Diagnosis and Treatment (3 papers), Lung Cancer Treatments and Mutations (3 papers) and Hemophilia Treatment and Research (2 papers). The work is most often cited by research in Otorhinolaryngology (78 citations), Hematology (93 citations), Oncology (194 citations), Virology (29 citations) and Pulmonary and Respiratory Medicine (160 citations). James Fetten has collaborated with scholars based in United States, China and Thailand. Frequent co-authors include Willi Kreis, Daniel R. Budman, V. Vinciguerra, Myron Susin, Savita Pahwa, Mark H. Kaplan, Stuart M. Lichtman, Steven L. Allen, Eli Gilboa and M. G. Sarngadharan. Their work appears in journals such as Journal of Clinical Oncology, The American Journal of Medicine, Breast Cancer Research and Treatment, JCO Global Oncology and CA A Cancer Journal for Clinicians.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.